These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27620194)

  • 1. MK-8237: a house dust mite vaccine for treating allergic rhinitis, asthma and atopic dermatitis.
    Ferrando M; Bagnasco D; Passalacqua G; Varricchi G; Canonica GW
    Expert Opin Biol Ther; 2016 Nov; 16(11):1435-1441. PubMed ID: 27620194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Suggestions in Sublingual Immunotherapy for House Dust Mite- Related Allergic Diseases.
    Ferrando M; Bagnasco D; Passa-Lacqua G; Puggioni F; Varricchi G; Canonica GW
    Curr Pharm Biotechnol; 2017; 18(5):378-383. PubMed ID: 28413977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical practice recommendations for allergen-specific immunotherapy in children: the Italian consensus report.
    Pajno GB; Bernardini R; Peroni D; Arasi S; Martelli A; Landi M; Passalacqua G; Muraro A; La Grutta S; Fiocchi A; Indinnimeo L; Caffarelli C; Calamelli E; Comberiati P; Duse M;
    Ital J Pediatr; 2017 Jan; 43(1):13. PubMed ID: 28257631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ
    Vitiello G; Maltagliati L; Rossi O
    Clin Mol Allergy; 2020; 18():10. PubMed ID: 32536827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines.
    Larenas-Linnemann D; Rodríguez-Pérez N; Luna-Pech JA; Rodríguez-González M; Blandón-Vijil MV; Del-Río-Navarro BE; Costa-Domínguez MDC; Navarrete-Rodríguez EM; Macouzet-Sánchez C; Ortega-Martell JA; Pozo-Beltrán CF; Estrada-Cardona A; Arias-Cruz A; Rodríguez Galván KG; Brito-Díaz H; Canseco-Raymundo MDR; Castelán-Chávez EE; Escalante-Domínguez AJ; Gálvez-Romero JL; Gómez-Vera J; González-Díaz SN; Guerrero-Núñez MGB; Hernández-Colín DD; Macías-Weinmann A; Mendoza-Hernández DA; Meneses-Sánchez NA; Mogica-Martínez MD; Moncayo-Coello CV; Montiel-Herrera JM; O'Farril-Romanillos PM; Onuma-Takane E; Ortega-Cisneros M; Rangel-Garza L; Stone-Aguilar H; Torres-Lozano C; Venegas-Montoya E; Wakida-Kusunoki G; Partida-Gaytán A; López-García AI; Macías-Robles AP; Ambriz-Moreno MJ; Azamar-Jácome AA; Beltrán-De Paz CY; Caballero-López C; Fernández de Córdova-Aguirre JC; Fernández-Soto JR; Lozano-Sáenz JS; Oyoqui-Flores JJ; Osorio-Escamilla RE; Ramírez-Jiménez F; Rivero-Yeverino D; Martínez Infante E; Medina-Ávalos MA
    World Allergy Organ J; 2020 Aug; 13(8):100444. PubMed ID: 32884611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber.
    Nolte H; Maloney J; Nelson HS; Bernstein DI; Lu S; Li Z; Kaur A; Zieglmayer P; Zieglmayer R; Lemell P; Horak F
    J Allergy Clin Immunol; 2015 Jun; 135(6):1494-501.e6. PubMed ID: 25636947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International consensus on allergy immunotherapy.
    Jutel M; Agache I; Bonini S; Burks AW; Calderon M; Canonica W; Cox L; Demoly P; Frew AJ; O'Hehir R; Kleine-Tebbe J; Muraro A; Lack G; Larenas D; Levin M; Nelson H; Pawankar R; Pfaar O; van Ree R; Sampson H; Santos AF; Du Toit G; Werfel T; Gerth van Wijk R; Zhang L; Akdis CA
    J Allergy Clin Immunol; 2015 Sep; 136(3):556-68. PubMed ID: 26162571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guideline recommendations on the use of allergen immunotherapy in house dust mite allergy: Time for a change?
    Calderón MA; Bousquet J; Canonica GW; Cardell LO; Fernandez de Rojas DH; Kleine-Tebbe J; Demoly P
    J Allergy Clin Immunol; 2017 Jul; 140(1):41-52. PubMed ID: 28526624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of house dust mite allergy.
    Yang L; Zhu R
    Hum Vaccin Immunother; 2017 Oct; 13(10):2390-2396. PubMed ID: 28853977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care: study design and recruitment.
    de Bot CM; Moed H; Berger MY; Röder E; de Groot H; de Jongste JC; van Wijk RG; van der Wouden JC
    BMC Fam Pract; 2008 Oct; 9():59. PubMed ID: 18937864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on allergen immunotherapy.
    Arshad SH
    Clin Med (Lond); 2016 Dec; 16(6):584-587. PubMed ID: 27927826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Good clinical practice recommendations in allergen immunotherapy: Position paper of the Brazilian Association of Allergy and Immunology - ASBAI.
    Aarestrup FM; Taketomi EA; Santos Galvão CE; Gagete E; Nóbrega Machado Arruda AC; Alves GB; Véras de Araújo Gueiros Lira G; Gonçalves MR; Couto Miziara MG; Maranhão Casado SS; Curi SV; Rufino Pereira VA; Sales V; Solé D; de Paula Motta Rubini N; Cavalcanti Sarinho ES
    World Allergy Organ J; 2022 Oct; 15(10):100697. PubMed ID: 36254179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision Medicine in House Dust Mite-Driven Allergic Asthma.
    Eguiluz-Gracia I; Palomares F; Salas M; Testera-Montes A; Ariza A; Davila I; Bartra J; Mayorga C; Torres MJ; Rondon C
    J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33255966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy and Asthma in Children.
    Tosca MA; Licari A; Olcese R; Marseglia G; Sacco O; Ciprandi G
    Front Pediatr; 2018; 6():231. PubMed ID: 30186823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study.
    Fritzsching B; Contoli M; Porsbjerg C; Buchs S; Larsen JR; Elliott L; Rodriguez MR; Freemantle N
    Lancet Reg Health Eur; 2022 Feb; 13():100275. PubMed ID: 34901915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High baseline prevalence of atopic comorbidities and medication use in children treated with allergy immunotherapy in the REAl-world effeCtiveness in allergy immunoTherapy (REACT) study.
    Fritszching B; Porsbjerg C; Buchs S; Larsen JR; Freemantle N; Contoli M
    Front Pediatr; 2023; 11():1136942. PubMed ID: 37063677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergen immunotherapy: 100 years, but it does not look like.
    Frati F; Incorvaia C; Lombardi C; Senna G
    Eur Ann Allergy Clin Immunol; 2012 Jun; 44(3):99-106. PubMed ID: 22905590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. House dust mite subcutaneous immunotherapy in Chinese patients with allergic asthma and rhinitis.
    Feng M; Zeng X; Li J
    J Thorac Dis; 2019 Aug; 11(8):3616-3625. PubMed ID: 31559069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.